2Flo Ventures
Vivacelle Bio Featured in The Lancet Journal
January 28, 2024
Vivacelle Bio has been featured in the esteemed Lancet Journal. In the link below, it details the results and significance of their positive Phase 2A data for their treatment of hypovolemia due to septic shock.
Learn more here: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00009-9/fulltext